Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.
Incidence of cetuximab-related infusion reactions in oncology patients treated at the University of North Carolina Cancer Hospital.
Systematic review on infusion reactions associated with chemotherapies and monoclonal antibodies for metastatic colorectal cancer.
Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.
High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history.